Monday, May 2, 2011

Clinical Practice Guidelines: Not Just For Cancer Anymore

The lack of standardization of healthcare in the U.S. has led to shocking variations in treatment outcomes and equally shocking cost differentials, to the point that in some places, and for some conditions, more money is spent to deliver worse outcomes.

As a consequence, clinical practice guidelines will be developed and refined to achieve the goal of standardizing care across providers and geographies.

Oncologists are the Vanguard of the Guidelines-Centered Future

Wednesday, April 20, 2011

Direct-to-Consumer Genetic Testing: What Happens After The Results Are Back?

The growing phenomenon of genetic testing will give consumers a blurry crystal ball that, like the fortune-telling of fairy tales or mythology, is certain to create as much conflict as it averts.

But manufacturers of direct-to-consumer (DTC) genetic tests -- as well as the companies that make the therapeutic interventions that might be used as a result of such tests -- have an opportunity as a result.

By satisfying customer cravings for guidance about when and how to use DTC genetic tests, manufacturers have the opportunity to establish a distinctive foothold in the marketplace.

And manufacturers need to do this before it is done for them in ways they might not want.

Tuesday, April 12, 2011

Do the Math: Nurse Practitioner Scope of Practice Must Multiply

The expanding role of nurse practitioners will have to expand to fill the gap created by a physician shortage and to release some of the pressures on a system that's over-priced, over-burdened, and under-resourced.

The average primary care physician today carries an annual caseload of approximately 2,400 patients, requiring physicians to see patient after patient throughout the day at a breakneck pace. Even though there are many more diagnostic codes and therapies than ever before, the average patient spends far less time with his or her physician than at any time in the past.

In the next 20 years, both the number of people aged 65 and older, and the percentage of the U.S. population they represent, will increase substantially. Chronic illness affects over 80 percent of older adults and consumes disproportionate resources. Almost a quarter of older adults have five or more chronic conditions, regularly visit 13 different physicians, and fill over 50 prescriptions annually.

Monday, March 21, 2011

Healthcare cost savings from expanded access to preventive medicine could be dead on arrival

Enormous, and enormously unrealistic, hope is being placed on preventing illness and its complications as a means to improving health outcomes and containing healthcare costs.

A major criticism of the U.S. fee-for-service healthcare model is that it rewards the treatment of health problems over their prevention. Much of the effort at reform is aimed at revising incentives to motivate providers to deliver preventive medicine.

The logic is that if physicians and other providers are compensated for a focus on prevention, and patients have access to affordable primary care, then people will be motivated to use that care and do the things needed to stay healthy. The reality, however, may be quite different.

Friday, March 18, 2011

Emerging notions of 'Valued-Based Health Care' are raising the bar and extending forecasting horizons for new drug therapies

Not long ago, a New England Journal of Medicine article, "What is Value in Health Care?" by Harvard Business School professor Michael Porter, offered up an analysis of healthcare value and its measurement in health outcomes research. Porter, along with and his colleague and co-author Elizabeth Olmsted Teisberg, describe three types (tiers) of health outcomes:

  • Health status achieved or retained -- survival, degree of health/recovery
  • Process of recovery -- time to recovery/normal living, short-term liabilities of treatment
  • Sustainability of health -- time to/nature of recurrences, longer-term liabilities of therapy

This "Outcome Measures Hierarchy" is being used by a growing number of large multi-hospital providers, small group practices, health plans, and employers in the U.S. and abroad as they work toward implementing value-based principles to guide therapy choices and outcome assessments.